RIVASTIGMINE 4.6 MG/24HR PATCH

rivastigmine
$1.8083per EA

Strength

4.6 mg/24h

Manufacturer

Sandoz Inc.

NDC

00781730431

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022083

On Market Since

9/2/2015

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-1.9%

3M

-3.9%

6M

+1.0%

1Y

-4.8%

3Y

-12.8%

5Y

-33.7%

All

-82.3%